{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1186/s12859-018-2220-4",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.agents/scmfdd",
      "@type": "sc:SoftwareApplication",
      "bioagents:primaryContact": [
        "Wen Zhang",
        "Feng Liu"
      ],
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:additionalType": "Web service",
      "sc:applicationSubCategory": {
        "@id": "edam:topic_3307"
      },
      "sc:citation": {
        "@id": "https://doi.org/10.1186/s12859-018-2220-4"
      },
      "sc:description": "Similarity constrained matrix factorization method for the drug-disease association prediction, which makes use of known drug-disease associations, drug features and disease semantic information. It projects the drug-disease association relationship into two low-rank spaces, which uncover latent features for drugs and diseases, and then introduces drug feature-based similarities and disease semantic similarity as constraints for drugs and diseases in low-rank spaces.",
      "sc:featureList": {
        "@id": "edam:operation_2409"
      },
      "sc:name": "SCMFDD",
      "sc:operatingSystem": [
        "Linux",
        "Windows",
        "Mac"
      ],
      "sc:softwareHelp": {
        "@id": "http://www.bioinfotech.cn/static/DrugDisease/data/User%20Manual%20for%20SCMFDD.pdf"
      },
      "sc:url": "http://www.bioinfotech.cn/SCMFDD/"
    }
  ]
}